The Case of the Missing Mole

When Costly Lost or Missing Laboratory Test Samples Instigate
Courier Management Redesign

GET YOUR FREE WHITEPAPER
MCE_White-paper_cover

MCE_logov3

 

Author: Liz Carey

Advisor: Linda S. Flynn, MS, MBA, MT(ASCPSBB)

Mishandling lab samples can be costly.

From the emergency department (ED) to physician offices and multiple clinics in the community and region, patient specimens can travel great distances before reaching the lab. However, labs and hospitals struggle to handle their in-house courier operations efficiently, effectively, and safely. 

Incidents of lost or missing laboratory test samples carry heavy consequences. Yet, many laboratories find that accountability, reconciliation, and tracking persist as issues.

This white paper will be useful for laboratory directors, lab managers, courier managers, logistics managers, and outreach managers—whether in hospital-based laboratories or independent medical laboratories working as outreach labs—who employ and manage couriers in-house.

MCE_White-paper_secondary

Table of Contents

Part 1: Performance Indicators for Monitoring In-House or Outsourced Courier Operations

Incidents of lost or missing laboratory test samples carry heavy consequences. Yet, many laboratories find that accountability persists as an issue. Explore three tipping points related to specimen management issues and learn from the experience of a nonprofit health system that redesigned its courier operations.

 

Part 2: Mapping a Medical Courier Redesign Initiative 

While sensitive and irreplaceable specimens are at risk particularly, all sample transportation must be monitored for quality and accountability. Discover 10 areas to analyze, a reference chart with actionable medical courier improvement measures, and discussion points for courier quality management teams.

 

Complete the form below to get your free white paper

The Dark Intelligence Group is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. In exchange for providing this free content, we may share your information with the companies whose content you choose to view. By accessing the white paper, you’re agreeing to the above.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

 

You Might Also Be Interested In....

White-Paper-Repurposing-Labs-Leftover-COVID-Samples-Dark-Daily-05-26-21_Page_01
Kapios_WP_October_2021
NovoPath_White_Paper